| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
SRA
|
GSE245781
|
Dec 02, 2023
|
||||||
| GSM7848960 |
thioridazine-treated, small group, stage 35, sample 1
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848961 |
thioridazine-treated, small group, stage 35, sample 2
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848962 |
thioridazine-treated, small group, stage 35, sample 3
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848963 |
control, small group, stage 35, sample 1
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848964 |
control, small group, stage 35, sample 2
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848965 |
control, small group, stage 35, sample 3
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848966 |
thioridazine-treated, large group, stage 35, sample 1
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848967 |
thioridazine-treated, large group, stage 35, sample 2
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848968 |
thioridazine-treated, large group, stage 35, sample 3
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848969 |
control, large group, stage 35, sample 1
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848970 |
control, large group, stage 35, sample 2
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 | |||
| GSM7848971 |
control, large group, stage 35, sample 3
|
SRA | 1 |
|
Megan M Sperry | Dec 02, 2023 |
